Literature DB >> 21849010

Effectiveness of interventions to improve antidepressant medication adherence: a systematic review.

W W Chong1, P Aslani, T F Chen.   

Abstract

Non-adherence to antidepressant medications is a significant barrier to the successful treatment of depression in clinical practice. This review aims to systematically assess the effectiveness of interventions for improving antidepressant medication adherence among patients with unipolar depression, and to evaluate the effect of these interventions on depression clinical outcomes. MEDLINE, PsycINFO and EMBASE databases were searched for English-language randomised controlled trials published between January 1990 and December 2010 on interventions to improve antidepressant adherence. The impact of interventions on antidepressant medication adherence (compliance and persistence) and depression clinical outcomes was evaluated. Data concerning the quality of the included studies were also extracted. Twenty-six studies met the inclusion criteria. Interventions were classified as educational, behavioural and multifaceted interventions. A total of 28 interventions were tested, as two studies investigated two interventions each. Sixteen (57%) of the 28 interventions showed significant effects on antidepressant adherence outcomes, whereas 12 (43%) interventions demonstrated significant effects on both antidepressant adherence and depression outcomes. The interventions which showed significant improvement in outcomes were primarily multifaceted and complex, with proactive care management and involvement of mental health specialists. The most commonly used elements of multifaceted interventions included patient educational strategies, telephone follow-up to monitor patients' progress, as well as providing medication support and feedback to primary care providers. Overall, educational interventions alone were ineffective in improving antidepressant medication adherence. In conclusion, improving adherence to antidepressants requires a complex behavioural change and there is some evidence to support behavioural and multifaceted interventions as the most effective in improving antidepressant medication adherence and depression outcomes. More carefully designed and well-conducted studies are needed to clarify the effect of interventions in different patient populations and treatment settings.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21849010     DOI: 10.1111/j.1742-1241.2011.02746.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  34 in total

1.  Potential Impact of Incorporating a Patient-Selected Support Person into mHealth for Depression.

Authors:  James E Aikens; Ranak Trivedi; Alicia Heapy; Paul N Pfeiffer; John D Piette
Journal:  J Gen Intern Med       Date:  2015-06       Impact factor: 5.128

Review 2.  Paroxetine-The Antidepressant from Hell? Probably Not, But Caution Required.

Authors:  Robert M Nevels; Samuel T Gontkovsky; Bryman E Williams
Journal:  Psychopharmacol Bull       Date:  2016-03-01

Review 3.  Review of community pharmacy staff educational needs for supporting mental health consumers and carers.

Authors:  Amary Mey; Jane L Fowler; Kathy Knox; David H K Shum; Jasmina Fejzic; Laetitia Hattingh; Denise McConnell; Amanda Wheeler
Journal:  Community Ment Health J       Date:  2013-01-10

4.  Examining Parental Medication Adherence as a Predictor of Child Medication Adherence in Pediatric Anxiety Disorders.

Authors:  Greta A Bushnell; M Alan Brookhart; Bradley N Gaynes; Scott N Compton; Stacie B Dusetzina; Til Stürmer
Journal:  Med Care       Date:  2018-06       Impact factor: 2.983

5.  [Costs and associated factors with optimal and suboptimal responses to the treatment of major depressive disorder].

Authors:  Antoni Sicras-Mainar; Jorge Mauriño; Luis Cordero; Milagrosa Blanca-Tamayo; Ruth Navarro-Artieda
Journal:  Aten Primaria       Date:  2012-07-11       Impact factor: 1.137

6.  Value-Based Benefit Design to Improve Medication Adherence for Employees with Anxiety or Depression.

Authors:  Kimberly J Reid; Kathleen M Aguilar; Eric Thompson; Ross M Miller
Journal:  Am Health Drug Benefits       Date:  2015 Jul-Aug

7.  Factors associated with antidepressant medication adherence and adherence-enhancement programmes: a systematic literature review.

Authors:  Gwen van Servellen; Barbara A Heise; Robin Ellis
Journal:  Ment Health Fam Med       Date:  2011-12

8.  Health care providers' perspectives of medication adherence in the treatment of depression: a qualitative study.

Authors:  Wei Wen Chong; Parisa Aslani; Timothy F Chen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-11-20       Impact factor: 4.328

9.  [Views of patients diagnosed with depression and cared for by general practitioners and psychiatrists].

Authors:  Carlos Calderón Gómez; Ander Retolaza Balsategui; Janire Payo Gordon; Amaia Bacigalupe De La Hera; Eskarne Zallo Atxutegi; Isabel Mosquera Metcalfe
Journal:  Aten Primaria       Date:  2012-05-08       Impact factor: 1.137

10.  Delayed educational reminders for long-term medication adherence in ST-elevation myocardial infarction (DERLA-STEMI): protocol for a pragmatic, cluster-randomized controlled trial.

Authors:  Noah M Ivers; Jon-David Schwalm; Jeremy M Grimshaw; Holly Witteman; Monica Taljaard; Merrick Zwarenstein; Madhu K Natarajan
Journal:  Implement Sci       Date:  2012-06-09       Impact factor: 7.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.